A phase II and pharmacokinetic study of SB-715992, in patients with metastatic hepatocellular carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG IND.168)
暂无分享,去创建一个
E. Eisenhauer | L. Seymour | S. Gill | J. Biagi | J. Knox | R. Feld | T. Synold | P. Major | C. Cripps | N. Wainman